In the HCC and hepatoblastoma mouse models mentioned above [71,81,82], we observed a reversal of this metabolic dependency, It is therefore not immediately clear that increasing PDC activity even further with a drug such as DCA would necessarily impact the growth of such tumors. This evidence concerns the gene PDC and hepatocellular carcinoma.